Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Jaguarhealth.gcs-web.com save search
Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
Published: 2023-02-01 (Crawled : 14:00) - jaguarhealth.gcs-web.com
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
|
| O: 1.76%
H: 0.0%
C: -1.72%
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
|
| O: -0.86%
H: 1.73%
C: 1.08%
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 3.97%
H: 1.7%
C: -3.61%
health
Jaguar Health Provides Update on Monitoring Trading Activity to Identify Possible Illegal Short Selling
Published: 2023-04-06 (Crawled : 13:00) - jaguarhealth.gcs-web.com
PPRUF | News | $364.27 37.56% 850
|
Consumer Non-Durables
|
| O: -0.65%
H: 0.06%
C: -1.52%
PPRUY | News | $36.96 -0.11% 220K
|
Manufacturing
|
| O: -2.29%
H: 1.57%
C: 1.4%
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 0.02%
H: 1.74%
C: -5.26%
health update
Jaguar Health Subsidiary Receiving Preclinical Services from the National Institute of Allergy and Infectious Diseases for New Preclinical Study Initiated January 6, 2021 for Lechlemer Plant-Based Drug Candidate for the Symptomatic Relief of Diarrhea from
Published: 2021-01-06 (Crawled : 14:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 4.62%
H: 12.75%
C: -1.47%
disease drug diarrhea infectious disease preclinical pre-clinical
REMINDER: Jaguar Health to Host Investor Call Thursday, December 17, 2020 to Allow Management to Review Developments Since the Definitive Proxy Statement for the Company’s December 9, 2020 Special Meeting of Stockholders Was Filed
Published: 2020-12-15 (Crawled : 17:31) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 0.15%
H: 29.32%
C: 19.52%
Nasdaq's Listing and Hearing Review Council Stays Panel Determination Requiring Jaguar Health's Compliance with the Bid Price Requirement by December 23, 2020
Published: 2020-12-07 (Crawled : 17:31) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -0.58%
H: 29.0%
C: 19.24%
Jaguar Health Announces Plan to Develop and Commercialize Crofelemer, the Company's Novel Proprietary Drug, for the Indication of Inflammatory Diarrhea, Initially in 'Long-Hauler' COVID-19 Recovery Patients
Published: 2020-11-30 (Crawled : 17:31) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 2.14%
H: 81.82%
C: 63.12%
covid drug diarrhea commercialization crofelemer
Jaguar Health Announces Release of Podcast Interview with The Wall Street Resource
Published: 2020-11-24 (Crawled : 17:31) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 3.16%
H: 0.92%
C: -2.7%
health
Jaguar Health, Inc. Reports 2020 Third Quarter Financial Results
Published: 2020-11-16 (Crawled : 17:31) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: -2.5%
results health
Jaguar Health to Host Investor Call Monday, November 16th at 8:30 a.m. Eastern Regarding Q3 2020 Financials & Business Updates
Published: 2020-11-10 (Crawled : 17:31) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 5.97%
H: 5.68%
C: -0.47%
Jaguar Health and Sponsor of Proposed Post Pandemic Recovery Equity SPAC to Host Webcast Wednesday, January 27th at 8:30 AM Eastern Time to Provide Updates Regarding the Potential Merger of Napo EU, the Company’s Anticipated Subsidiary in Italy
Published: 2021-01-21 (Crawled : 14:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 16.1%
H: 0.59%
C: -8.26%
spac merge potential
Jaguar Health Announces Closing of $6.0 Million Issuance and Sale of Designation-backed Note Related to Possible Tropical Disease Priority Review Voucher
Published: 2021-01-20 (Crawled : 14:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -5.08%
H: 0.84%
C: -5.93%
disease designation tropical disease
Jaguar Health Exploring Possibility of Conditional Marketing Authorization for Proposed Inflammatory Diarrhea Indication for Crofelemer, Initially in ‘Long-Hauler’ COVID-19 Recovery Patients in Europe
Published: 2021-01-11 (Crawled : 14:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -3.75%
H: 9.09%
C: -6.49%
covid diarrhea europe authorized crofelemer
Jaguar Health Subsidiary Receiving Preclinical Services from the National Institute of Allergy and Infectious Diseases for New Preclinical Study Initiated January 6, 2021 for Lechlemer Plant-Based Drug Candidate for the Symptomatic Relief of Diarrhea from Cholera
Published: 2021-01-06 (Crawled : 16:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 4.62%
H: 12.75%
C: -1.47%
disease drug diarrhea infectious disease preclinical pre-clinical
Jaguar Health to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference the Week of January 11th and at 4:30 pm Eastern on Tuesday, January 19th at the NobleCon17 Virtual Conference
Published: 2021-01-12 (Crawled : 14:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -10.28%
H: 6.5%
C: 4.64%
Jaguar Health Announces $15 Million Registered Direct Offering Priced Above-the-Market Under Nasdaq Rules
Published: 2021-01-13 (Crawled : 13:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 13.61%
H: 2.34%
C: -3.91%
offering health nasdaq
Jaguar Health Enters Non-dilutive Binding Term Sheet for $6.0 Million Sale of Partial Rights to Possible Tropical Disease Priority Review Voucher
Published: 2021-01-13 (Crawled : 13:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 13.61%
H: 2.34%
C: -3.91%
disease tropical disease
REMINDER: Jaguar Health and Sponsor of Proposed Post Pandemic Recovery Equity SPAC to Host Webcast Wednesday, January 27th at 8:30 AM Eastern Time to Provide Updates Regarding the Potential Merger of Napo EU, the Company’s Anticipated Subsidiary in Italy
Published: 2021-01-26 (Crawled : 14:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 1.2%
H: 0.0%
C: -3.26%
spac merge potential
Jaguar Health's Chief of Sustainable Supply, Dr. Steven King, an Ethnobotanist, to Discuss Crofelemer Development on February 4th at 2 PM Eastern as Part of the American Botanical Council's Sustainable Herbs Program Webinar Series
Published: 2021-02-03 (Crawled : 14:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 2.2%
H: 3.58%
C: 2.15%
crofelemer
Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
Published: 2021-01-22 (Crawled : 14:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 0.64%
H: 9.97%
C: 3.51%
health nasdaq
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-01-22 (Crawled : 22:08) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
| Email alert
Add to watchlist
granted health grant
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.